Peptidomic analysis of CSF reveals new biomarker candidates for amyotrophic lateral sclerosis

Peptidomic analysis of CSF reveals new biomarker candidates for amyotrophic lateral sclerosis

Abstract Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease, and novel biomarkers are needed. We applied mass-spectrometry-based peptidomic analysis in cerebrospinal fluid (CSF) samples of ALS and non-neurodegenerative control patients (Con) from a discovery (n = 48) and...

Full description

Saved in:
Bibliographic Details
Main Authors: Besnik Muqaku, Johannes Dorst, Maximilian Wiesenfarth, Markus Otto, Albert C Ludolph, Patrick Oeckl
Format: Article
Language:English
Published: Springer Nature 2025-07-01
Series:EMBO Molecular Medicine
Subjects:
ALS
Peptidomics
Biomarker
Neurodegeneration
Muscle
Online Access:https://doi.org/10.1038/s44321-025-00272-w
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items